Search Results for "Fingolimod Hplc Method"
Original Source: Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry.
The detection of diabetic metabolism disorders raises problems in forensic practice and sudden death with a subsequent negative autopsy finding is a common problem. In the case of an unclear hypoglycaemia, the detection of oral antidiabetics allows the differentiation of hypoglycaemia due to oral antidiabetics from that due to other reasons (insulin-induced, insulinoma). The development of an electrospray ionisation (ESI) liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for the simultaneo...
Matching Channels
Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-labeled nucleic acid...
The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...
Drug Delivery - news, views, blogs
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Drug delivery technologies are patent protected formulat...
Herpes simplex virus HSV 1 HSV 2 HHV 1 HHV 2
Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the vira...
Testicular cancer represents only 1 per cent of all cancers in men, but it is the single biggest cause of cancer-related deaths in men aged 15-35 years in the UK. The causes of testicular cancer and...
Matching News
The Hamilton PRP™-C18 Reversed-Phase HPLC Column is designed to increase the accuracy and quality of separations performed by pharmaceutical companies, environmental scientists, and others.Read more...
Porvair Sciences Speeds Up Evaporation of HPLC Solvents
Combining a new 48-well needle head with a dedicated HPLC vial holder that accepts 48 standard 1.5ml vials transforms any MiniVap or UltraVap system into a high throughput HPLC sample evaporator.
HPLC Assay of Gentamicin Sulfate Congeners in Just 15 Minutes
Thermo Fisher Scientific is pleased to announce a direct-detection reversed-phase high-performance liquid chromatography (HPLC) chromatographic assay method that separates the congeners in gentamic...
HPLC Column Streamlines Productivity
Hamilton Company's Laboratory and Sensor Products Division has introduced the Hamilton PRP-C18 reversed-phase HPLC column, designed to increase accuracy of separations performed by pharmaceutical comp...
Fingolimod: 'Hint' of advantages in a small group of patients
The immunosuppressive drug fingolimod (trade name: Gilenya) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursu...
Provair Sciences has introduced a new version of its MiniVap and UltraVap blowdown evaporators that use warm air or nitrogen to speed up the evaporation of common HPLC solvents such as dichloromethan...
Thermo Fisher Scientific has announced that its Syncronis HPLC columns are now available with 3 mm particle size. The new particle size complements the existing 1.7 and 5 mm particle sizes.Read more...
Fingolimod offers minor added benefit for patients with RRMS
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment purs...
Matching PubMed Articles
Does fingolimod in multiple sclerosis patients cause macular edema?
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system and is the common cause of optic neuritis. Fingolimod, an immunosuppressive agent, is used in MS to prevent acute exace...
The oral immunomodulator fingolimod (FTY720) has recently been shown to be highly effective in relapsing-remitting multiple sclerosis (MS). Fingolimod is a functional antagonist of the sphingosine-1-p...
INTRODUCTION. Fingolimod is the first approved drug with oral availability for the treatment of relapsing multiple sclerosis. AIMS. To review the mechanism of action of fingolimod and its relationship...
PURPOSE: Fingolimod (FTY720) is a sphingosine-1 phosphate-receptor (S1PR) modulator recently approved as a once-daily oral therapy for relapsing multiple sclerosis (MS) in many c...
Since April 2011 fingolimod (FTY 720, Gilenya®), a new oral treatment, is available for relapsing-remitting multiple sclerosis (MS) in Germany. Adverse effects in pre-marketing clinical controlled mu...
